12.07.2023
REN001-201
A DOUBLE-BLIND, PLACEBO-CONTROLLED, study to EVALUATE the EFFICACY and safety of 24 weeks treatment with REN001 in patients with primary mitochondrial myopathy (PMM)
Show more14.06.2023
PID-PED study KB070
A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety, and Pharmacokinetics of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Pediatric Patients Affected by Primary Immunodeficiency Disease (PID)
Show more